Corporate News – Market Update
Orgabio Bhd (ticker 0252.KL) finished the most recent trading session at a flat 0 % change, closing at MYR 0.28 on the exchanges. The stock remains highly liquid, with a current supply of 247.9 million shares and a market capitalisation of MYR 71.9 million. In the past 24 hours, trading volume was modest, amounting to approximately MYR 5.8 k of shares exchanged.
Recent Performance Metrics
| Metric | Value |
|---|---|
| Last 24‑hour change | 0 % (flat) |
| Last 24‑hour volume | MYR 5.8 k |
| Month‑end change | –4.92 % |
| 200‑day simple moving average | MYR 0.30 |
| 52‑week high | MYR 0.33 (10/19/2026) |
| 52‑week low | MYR 0.26 (10/19/2026) |
These figures suggest a period of consolidation for the company, with its price hovering near the lower end of its recent trading band.
Comparative Stock Performance
| Stock | Ticker | 24‑hour change | Current price | Market cap (MYR) | Notable ratios |
|---|---|---|---|---|---|
| Borneo Oil Bhd | 7036.KL | 0 % (flat) | 0.00 | 86.1 m | — |
| Grand Central | 5592.KL | +7.5 % | 0.44 | 84.7 m | — |
| Guan Huat Seng Bhd | 0387.KL | –5.26 % | 0.19 | 85.2 m | P/E = 11.57 |
| Resintech Bhd | 7232.KL | –1.15 % | 0.43 | 85.5 m | P/E = 5.44 |
| DC Healthcare Bhd | 0283.KL | 0 % (flat) | 0.08 | 84.7 m | P/E = 36.95 |
While Orgabio’s performance remains neutral, its peer Grand Central has delivered a notable uptick, whereas Guan Huat Seng and Resintech have experienced modest declines. DC Healthcare Bhd stands out for its high price‑to‑earnings ratio, signalling potential overvaluation relative to earnings.
Company Background
Orgabio Holdings Berhad, established in 1988, is a prominent Malaysian player in the electronic and telecommunications sector. The firm specialises in the production and distribution of a broad array of communication equipment, targeting both consumer and enterprise markets. Over the decades, Orgabio has cultivated strategic partnerships and invested in product innovation, positioning itself as a key contributor to Malaysia’s expanding telecommunications infrastructure.
Outlook
With the stock price aligning closely with its 200‑day moving average and its current trading range confined between the 52‑week high and low, investors may view Orgabio as a stable yet unremarkable holding at this juncture. The company’s continued focus on innovation and partnership development could offer upside potential, but market sentiment appears cautious, as reflected in the flat daily movement and modest volume. Market participants will likely monitor any forthcoming earnings announcements or product launches that could shift the narrative in Orgabio’s favour.
